SBUK 2023 takes place in Bristol

Over 300 people from 45 institutions in 11 countries attended the Synthetic Biology 2023 conference in Bristol on 6-7 November, organised by the Biochemical Society and the Bristol BioDesign Institute.

We would like to thank all the invited speakers (Prof Patrick CaiProf Tanja KortemmeProf Petra SchwilleProf Andreas PlückthunProf Susan RosserProf Seraphine WegnerProf Julius LucksDr David RiglarDr Nicole Wheeler and Dr Gitta Neufang), the oral and poster presenters, the session chairs, the team from the Biochemical Society, and everyone else who attended for their help in making the event a great success.

Themes covered at the conference included biomolecular design and engineering; cell and system-level design; synthetic and minimal cells; data-centric bioengineering, and applications across industry.

Dek Woolfson presents Stephen Wallace with the Colworth Medal.Congratulations to Prof Stephen Wallace, who was awarded the prestigious Colworth Medal and gave a talk on the development of ‘plastic-eating E. coli that can efficiently turn polyethylene terephthalate (PET) waste into adipic acid, which is used to make nylon materials, drugs and fragrances’.

Further congratulations to the oral and poster prize recipients:

Synthetic Biology UK 2023

The Biochemical Society and the Bristol BioDesign Institute are working together to organise this year’s Synthetic Biology UK meeting, which will take place in Bristol on 6-7 November.

Registration is now open. The deadline for submitting abstracts (and for early registration) is Wednesday 6 September 2023. 

Synthetic biology is a maturing field at the confluence of the biosciences, physical sciences, information technology, and engineering and is rapidly beginning to demonstrate valuable solutions to some of our most pressing global challenges in healthcare, agriculture, sustainability and the environment.

SBUK 2023 will bring the synthetic and engineering biology communities together in Bristol, a city with a rich and long-standing history in engineering and a vibrant research community in synthetic biology, to share recent scientific advancements across the field. Conference themes will include biomolecular design and engineering; cell and system-level design; synthetic and minimal cells; data-centric bioengineering, and applications across industry.

The diverse and inclusive programme will include opportunities for networking, and an emphasis will be placed on ensuring the event offers early career researchers with the vital opportunities needed to build their wider research networks with leading experts in the field, as well as gain insights into careers in industry, SMEs, policy, academia and innovation delivery.

Confirmed speakers include: Prof Patrick Cai, Prof Tanja Kortemme, Dr Gitta Neufang, Prof Andreas Plückthun, Dr David Riglar, Prof Susan Rosser, Prof Petra Schwille, Prof Seraphine Wegner, Prof Julius Lucks, and Dr Nicole Wheeler.

Banner contains details of the date, venue and website of the SBUK conference.

Bristol’s pioneering COVID-19 research prompts French Embassy visit

Representatives from the French Embassy visited University labs on 10 December to see some of the innovative COVID-19 research being undertaken at Bristol, including work on ADDomer™, a thermostable vaccine platform being developed by Bristol scientists to combat emerging infectious diseases.

Dr Rachel Millet and Arthur Belaud from the Embassy’s Innovation Branch, which seeks to drive France-UK business enterprise, met with scientists Professor Imre Berger and Frederic Garzoni, founders of Imophoron Ltd, the biotech start-up developing ADDomer that uses technology developed at an institution in France, and recently secured £4 million investment.

L to R: Arthur Belaud from the French Embassy, Dr Anne Westcott from the University, Dr Rachel Millet from the French Embassy and Professor Imre Berger at the University’s Max Planck Bristol Centre for Minimal Biology.

During the visit, the delegation took a tour of labs in the University’s Max Planck-Bristol Centre for Minimal Biology (MPBC), the GW4/Wellcome Trust Cryo-EM facility led by Prof Christiane Schaffitzel, and Science Creates, the Bristol-based incubator, which is operated in partnership with the University and supports scientists and engineers in commercialising ground-breaking innovations. Having recently opened its second facility in the city’s Old Market, the party met with Science Creates founder and Bristol graduate Dr Harry Destecroix to discuss the future of deep-tech eco-systems.

Professor Imre Berger, Director of Bristol’s Max Planck Centre for Minimal Biology, said: “We are honoured to host this visit from the French Embassy’s Innovation Branch to share knowledge and showcase the pioneering research that is being done in collaboration with our European colleagues and institutions.”

Press release issued: 10 December 2021 on University of Bristol News and Features~ article here.

A spotlight on Plant Synthetic Biology – BBI Webinar

This webinar is a spotlight on plant synthetic biology, featuring three rising stars in one dynamic interactive session. Three early career researchers, hosted by Dr. Thomas Gorochowski and Dr. Emily Larson, discuss plant biology topics including reprogramming plant root growth, genome engineering, and the biodesign potential of marchantia polymorpha. The speakers include:

  • Dr. Jennifer Brophy (keynote) – ‘Reprogramming plant root growth using synthetic developmental regulation.’
  • Dr Quentin Dudley – ‘Genome engineering of Nicotiana benthamiana as an improved plant-based bioproduction system for medicinal alkaloids.’
  • Dr Eftychis Frangedakis – ‘Marchantia polymorpha: an emerging system for plant synthetic biology.’

You can watch the full recording, including Q&A here:

BBI International Webinar Series – Professor Elisa Franco, UCLA

The Bristol BioDesign Institute‘s newly imagined webinar series for 2021 has been designed as a platform to invite the best international speakers that are aligned to our core areas of interest. These include; biomolecular design and assembly in the cell, development and delivery of bioactive molecules, minimal biology towards cell-like systems, advanced computing and digital biology. You can find our upcoming speakers for the year on the International Webinar Series section of our website.

The first speaker of 2021 is Professor Elisa Franco from UCLA, with BBI Directors, Thomas Gorochowski and Dek Woolfson, panelling. The seminar is followed by an audience Q&A session, and then a one-to-one interview where Dr. Gorochowski asks Professor Franco questions about how she got into synthetic biology and her predictions for its future. 

You can watch Professor Franco’s seminar, on ‘Programming dynamic behaviors in molecular systems and materials‘ below, or on the BBI YouTube Channel.

Abstract – Biological cells adapt, replicate, and self-repair in ways that are unmatched by man-made devices. These processes are enabled by the interplay of receptors, gene networks, and self-assembling cytoskeletal scaffolds. Taking inspiration from this architecture, we follow a reductionist approach to build synthetic materials by interconnecting nucleic acid components with the capacity to sense, compute, and self-assemble. Nucleic acids are versatile molecules whose interactions and kinetic behaviors can be rationally designed from their sequence content; further, they are relevant in a number of native and engineered cellular pathways, as well as in biomedical and nanotechnology applications. I will illustrate our approach with two examples. The first is the construction of self-assembling DNA scaffolds that can be programmed to respond to environmental inputs and to canonical molecular signal generators such as pulse generators and oscillators. The second is the encapsulation of these dynamic scaffolds in droplets serving as a mimic of cellular compartments. I will stress how mathematical modeling and quantitative characterization can help identify design principles, guide experiments, and explain observed phenomena.

BBI Webinar: Professor Domitilla Del Vecchio, MIT

Since the start of lockdown 1.0 in March 2020, the BBI has been hosting a series of virtual seminars. Speakers have included Professors Anne Osbourn, Christine Orengo, Andreas Plueckthun, and many others. Lockdown has allowed us to broaden our speaker base on an international level, with academics from the US, Israel and Switzerland.

On 11 November, we had Professor Domitilla Del Vecchio from the Massachusetts Institute of Technology (MIT) give a webinar on ‘Context dependence of biological circuits: Predictive models and engineering solutions’. Panellists for the event were some of our own University of Bristol academics Dr. Thomas Gorochowski and Prof. Claire Grierson.

You can watch the full recording of the webinar here:

DNA gets cool – the world of nucleic acid biomachinery.

Written by SynBio CDT students Claire Noble and Harry Thompson.

Do we have any chance of designing new ribosomes from scratch? Maybe not just yet, but that doesn’t mean Jon Bath, from the University of Oxford, isn’t getting started. While DNA origami hasn’t always been as glamorous as the world of protein design, that doesn’t mean there isn’t lots of exciting potential for new, DNA-based biomachinery.

The relatively simple nature of DNA folding based on base pairing has allowed for the construction of intricate and beautiful DNA structures. However, the field of designing DNA structure towards novel functionality is still being explored. In the past, DNA has been shown to be capable of moving along short tracks and assembling simple polymers in a directed way. Jon Bath is seeking to gain a deeper fundamental understanding of what dictates higher level folding in DNA origami, so that more complex designs can be attempted. He is making use of comparatively ‘simple’ DNA structures, with uncommon motif’s such as T-junctions, to try and elucidate the mechanisms behind self-assembly of complex origami.

By increasing our understanding of how DNA folds, design principles can then be applied towards constructions of functional origamis, of which there have been relatively few examples so far. A brave new world of DNA templated chemistry and molecular motors awaits!

Can we build a minimal form of life? A bottom-up perspective.

Hosted by Dr Thomas Gorochowski and PhD students Veronica Greco and Matthew Tarnowski from the Biocompute Lab

Dr Bert Poolman, a biochemist from the University of Groningen, visited Bristol on the 4th September to pose the question of whether it is possible to artificially create and control the physicochemistry of a cell. The ability to manipulate, control, or even create a new cell from scratch are fundamental directions for synthetic biology research.

What if we could build a cell in the lab?

Bert Poolman is part of an EU-wide project – aptly named BaSyC, or, ‘Building a Synthetic Cell’, which emerged in September 2017 combining leaders in physics, chemistry and biology from across the Netherlands to test out this theory.

“In the next decade they aim to achieve a physicochemical homeostatis in a cell where metabolic pathways and energy consumption/production systems can be better understood, optimised and synthetically built.” Veronica Greco explains. She was in the audience during his seminar.

Matthew Tarnowski, who also attended the seminar, said that Bert “highlighted some fascinating properties of cells: they are incredibly crowded, yet molecules move surprisingly fast within them.” Matthew was struck by Bert’s results demonstrating the sheer complexity of cells. “He [Bert] showed that engineering systems that mimic fundamental cellular processes is challenging”.

What was the audience reaction?

Intrigued audience members questioned the sustainability of such an ambitious project, such as how to overcome the challenge of building a synthetic ribosome and the new methods required to carefully assemble the numerous parts of a synthetic cell in a controllable way.

“The talk left me curious about how minimal life research could be completed responsibly: have the economic, social and environmental impacts been anticipated?” Matthew pointed out that the purpose behind building minimal forms of life went unanswered.

Veronica ended by noting that, “Overall, it is a very well thought out project that will require lots of different expertise and time, and surely it has all the credentials to give a big contribution to science and to change once again how the growing scientific field of synthetic biology is perceived.”

Are you a PhD or Postdoc?

BaSyC are offering various work packages to PhDs and Postdocs within one of their partner institutions. Due to the interdisciplinary nature of the work (combining physicists, chemists and biologists), “working at different locations and labs is more the rule than the exception”. There are opportunities to be involved in BaSyC activities: progress meetings and trainings, summer schools and the biennial international symposium on Building a Synthetic Cell.

Interested in joining the project?

Visit the BaSyC website for more information.

No jobs available for the specific part of the programme you are interested in? Feel free to send an open application to the corresponding PI directly – the PI’s contact details can be found at their people page.

For general questions and queries: info@basyc.nl 

 

Biodesign companies make a splash at the inaugural Launch: Great West science innovation awards

Last night we got dressed up in our best frocks to attend the first Launch: Great West awards. The event aimed to celebrate the growing number of new companies in the SW that leverage the world-class science base of our local universities. It was a buzzing and incredibly professional evening thanks to the hard work of the organisers at Spin Up Science. As a headline sponsor, the Bristol BioDesign Institute was there on mass and we were over the moon to see that companies that use biodesign technologies swept the board, winning five of the eight awards.

The winners were:

The Ones to Watch Award: Rosa Biotech who use biodesign to develop novel sensors inspired by the mammalian olfactory system

The Rising Star Award: CytoSeek who develop new biodesign technologies to enhance cell therapies

The BioDesign Award: Ceryx Medical develop bioelectronics to mimic nerve centres within the body

The Global Good Award: Imophoron use biodesign to develop new types of vaccines to emerging developing-world diseases

The Deal of the Year Award: Ziylo/Carbometrics who took a biodesign approach to the development of new glucose binding molecules leading to a trade sale to Novo Nordisk of up to $800M

This event really shows how far the science entrepreneurship community has grown in the last few years. As our local MP Thangam Debbonaire said in the opening speech, Bristol is growing an amazing innovation ecosystem that builds on the best elements of the University, local industries and city as a whole.

We are very much looking forward to the next event to see if biodesign companies can do even better!